Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|November 27, 2012
Pharmacophore identification of c-Myc inhibitor 10074-G5Jeremy L Yap, Huabo Wang, Angela Hu, et al.
Drug Design, Development and Therapy|May 20, 2015
Structure-activity exploration of a small-molecule Lipid II inhibitorSteven Fletcher, Wenbo Yu, Jing Huang, et al.
Cancer Gene Therapy|April 20, 2022
3JC48-3 (methyl 4'-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1'-biphenyl]-3-carboxylate): a novel MYC/MAX dimerization inhibitor reduces prostate cancer growthSanjeev Shukla, Steven Fletcher, Jay Chauhan, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2012
Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabineChristine L Clouser, Jay Chauhan, Matthew A Bess, et al.
Plos One|January 26, 2011
Analysis of the ex vivo and in vivo antiretroviral activity of gemcitabineChristine L Clouser, Colleen M Holtz, Mary Mullett, et al.
Bioorganic & Medicinal Chemistry Letters|April 30, 2018
Kröhnke pyridines: Rapid and facile access to Mcl-1 inhibitorsIvie L Conlon, Daniel Van Eker, Sameh Abdelmalak, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2018
Discovery of Mcl-1 inhibitors based on a thiazolidine-2,4-dione scaffoldEllis Whiting, Mithun R Raje, Jay Chauhan, et al.
Bioorganic & Medicinal Chemistry|October 18, 2015
Synthetic, structural mimetics of the β-hairpin flap of HIV-1 protease inhibit enzyme functionJay Chauhan, Shen-En Chen, Katherine J Fenstermacher, et al.
Oncotarget|November 13, 2018
Erratum: Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5Huabo Wang, Jay Chauhan, Angela Hu, et al.
Oncotarget|June 27, 2013
Disruption of Myc-Max heterodimerization with improved cell-penetrating analogs of the small molecule 10074-G5Huabo Wang, Jay Chauhan, Angela Hu, et al.
Pageof 3